<code id='E20ADB7C79'></code><style id='E20ADB7C79'></style>
    • <acronym id='E20ADB7C79'></acronym>
      <center id='E20ADB7C79'><center id='E20ADB7C79'><tfoot id='E20ADB7C79'></tfoot></center><abbr id='E20ADB7C79'><dir id='E20ADB7C79'><tfoot id='E20ADB7C79'></tfoot><noframes id='E20ADB7C79'>

    • <optgroup id='E20ADB7C79'><strike id='E20ADB7C79'><sup id='E20ADB7C79'></sup></strike><code id='E20ADB7C79'></code></optgroup>
        1. <b id='E20ADB7C79'><label id='E20ADB7C79'><select id='E20ADB7C79'><dt id='E20ADB7C79'><span id='E20ADB7C79'></span></dt></select></label></b><u id='E20ADB7C79'></u>
          <i id='E20ADB7C79'><strike id='E20ADB7C79'><tt id='E20ADB7C79'><pre id='E20ADB7C79'></pre></tt></strike></i>

          fashion

          fashion

          author:explore    Page View:24
          The FDA building -- First Opinion coverage from STAT
          Adobe

          WASHINGTON — The Food and Drug Administration’s top cancer drug regulator doesn’t always ask for permission before taking on big initiatives.

          Richard Pazdur, director of the FDA Oncology Center of Excellence, hates bureaucracy. It stifles his ideas for getting treatments to cancer patients faster — of which there are many.

          advertisement

          To cut through that bureaucracy, Pazdur has a trick: “Don’t tell anybody,” he said to laughter at a meeting of the advocacy group Friends of Cancer Research Tuesday.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          The U.S. needs a new definition of substance use “recovery”
          The U.S. needs a new definition of substance use “recovery”

          Adobe“WhenIuseaword,”oneof19thcenturyBritishauthorandmathematicianLewisCarroll’scharactersoncesaid,“

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Humana’s losses in Medicare Advantage tank its stock

          Humana’sMedicareAdvantagebusinessisfaringevenworsethanthecompanyletonlastweek.EdReinke/APHumana’sMed